TissueForm, Inc.
Innovating biologic and regenerative medicine products | mission to improve quality of life for patients |
Innovating biologic and regenerative medicine products | mission to improve quality of life for patients |
TissueForm is a biotechnology startup founded in 2019 with a mission to address volumetric tissue loss using innovative biomaterials. The company focuses on leveraging the natural, restorative potential of the extracellular matrix to develop biomaterials tailored for plastic surgery and regenerative medicine. Their biomaterials, composed of cross-linkable tissue and protein components, closely mimic natural tissue when injected, presenting a promising solution to clinical challenges in the field. Noteworthy, TissueForm secured a $250.00K grant investment from the Advanced Industries Accelerator (AIA) Program on 18 May 2023, signifying recognition from industry players and potential for impactful innovation. This infusion of capital can fuel their research and development efforts, positioning TissueForm for growth and potentially attracting further interest from investors and strategic partners in the biotechnology and healthcare sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $250.00K | 1 | Advanced Industries Accelerator (AIA) Program | 18 May 2023 |
No recent news or press coverage available for TissueForm, Inc..
We care about your data, and we'd love to use cookies make your experience better.
